KYMR
KYMR
NASDAQ · Biotechnology

Kymera Therapeutics Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$127.87
-8.38 (-6.15%)
As of Nov 5, 7:55 PM ET ·
Analyst Consensus
Strong Buy
29
Analysts
High
Coverage
Buy 26 90%
Hold 3 10%
Sell 0 0%
Price Target
Analyst Price Target -75.7% upside
Low Target $20.33
Average Target $31.03
High Target $33.62
Current Price $127.87
Current
$127.87
Target
$31.03
$20.33 $31.03 avg $33.62
Scenario Analysis
Bear Case
$20.33
-84.1%
Low target
Base Case
$31.03
-75.7%
Avg target
Bull Case
$33.62
+-73.7%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$130.05
-1.7% from high
52-Week Low
$55.66
+129.7% from low
50-Day SMA
$115.38
+10.8% vs SMA
200-Day SMA
$97.33
+31.4% vs SMA
RSI (14)
84.2
Overbought
Target vs 52W High
$31.03
-76.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -35.8%